The interleukin-8 receptor: a potential target for antipsoriatic therapy?
- 1 June 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 258 (3) , 269-272
- https://doi.org/10.1016/0014-2999(94)90490-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNFPublished by Elsevier ,2004
- Interleukin-8 Stimulates Calcium Transients and Promotes Epidermal Cell ProliferationJournal of Investigative Dermatology, 1992
- Interleukin‐8 receptor‐mediated chemotaxis of normal human epidermal cellsFEBS Letters, 1992
- Defect of epidermal 12(S)-hydroxyeicosatetraenoic acid receptors in psoriasisEuropean Journal of Clinical Investigation, 1992
- Studies of the Effect of Cyclosporine in Psoriasis In Vivo: Combined Effects on Activated T Lymphocytes and Epidermal Regenerative MaturationJournal of Investigative Dermatology, 1992
- Effect of Ciclosporin on Epidermal 12(S)-Hydroxyeicosatetraenoic Acid Binding SitesSkin Pharmacology and Physiology, 1991
- Dithranol: A Review of the Mechanism of Action in the Treatment of Psoriasis vulgarisSkin Pharmacology and Physiology, 1990
- The Neutrophil-Activating Protein (NAP-1) Is Also Chemotactic for T LymphocytesScience, 1989
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- Identification of C5ades arg and an Anionic Neutrophil-Activating Peptide (ANAP) in Psoriatic ScalesJournal of Investigative Dermatology, 1986